Author

Judith Feucht

Memorial Sloan Kettering Cancer CenterORCID 0000-0002-8745-1079Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Assay:CITE-seq· 1 Approach:deep learning· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Achuth NairiD· 1 shared Alexander BirbrairiD· 1 shared Annalisa CabrioluiD· 1 shared Brian D. BrowniD· 1 shared Christos Patsis· 1 shared Darjus Felix TschaharganehiD· 1 shared Gertrude GunsetiD· 1 shared Hendrik WiethoffiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Achuth NairORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Dendritic cells accelerate CAR T cells in irradiated tumors through chimeric synapses

Sammy Navarre, Maki Ishibashi, Achuth Nair, Ivan Reyes-Torres, Meriem Belabed, László Halász, Matthew D. Park, Raphaël Mattiuz, Merouane Ounadjela, Gertrude Gunset, Jorge Mansilla‐Soto, Judith Feucht, Annalisa Cabriolu, Jessica Le Bérichel, Alexander Birbrair, , Jalal Uddin Ahmed

This study shows dendritic cells enhance CAR T cell persistence in irradiated tumors by antigen-dressing and stimulating CAR T cells through chimeric receptors.

Nature Cancer · May 22, 2026Peer-reviewedImmunology

Repurposing passenger amplifications as Trojan horses identifies MPZL1 as a potent target for solid cancers

Sonia Jiménez Vázquez, Christos Patsis, Mara Mitstorfer, Melanie Grimm, Luise Butthof, Lena Wendler-Link, Lio Böse, Hendrik Wiethoff, Ilse Hofmann, Kai Breuhahn, Thomas Longerich, Matthias M. Gaida, Peter Schirmacher, Judith Feucht, Marco Breinig, Darjus Felix Tschaharganeh

The paper identifies MPZL1 as a therapeutic target in 1q-amplified solid cancers by repurposing passenger amplifications as Trojan horses for targeted therapy delivery.

bioRxiv · Sep 17, 2025 · PreprintCancer Biology